September 11, 2017
1 min read
Save

Deep SSIs seen in 13% of patients who underwent repetitive surgery for non-idiopathic scoliosis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Michael Vitale

PHILADELPHIA — At the Scoliosis Research Society Annual Meeting, a presenter noted a deep infection rate of about 13% among patients who had growth-friendly procedures that necessitated repetitive surgery for non-idiopathic scoliosis. Expansions contributed to about 50% of these infections.

“Interestingly, and somewhat surprisingly and honestly contrasting to other work, we did not see a difference in [surgical site infections] SSI prevalence based on etiology, with rate being about the same for neuromuscular, congenital [and] syndromic patients,” Michael Vitale, MD, MPH, said during his presentation.

In a multicenter retrospective study, Vitale and colleagues used the Child’s Spine Study Group database to collect demographic and clinical characteristics of children with non-idiopathic scoliosis who required repetitive surgery. They identified 593 patients with either congenital, neuromuscular or syndromic scoliosis and underwent a total of 5,072 procedures. Deep SSI rates were assessed.

Results showed a 13% incidence of deep SSIs per patient. The risk of deep SSIs per procedure was 1.95%, with 99 SSIs reported throughout the study.

“About 20% of the time, infections are related to the implant and about 50% of the time, expansion; about 30% of the time, revision,” he said. “I think this is hopeful data in the era where we are doing much less repetitive surgery because if we can obviate the 50% of infections related to expansions, we can decrease the total of morbidity in infected children.” – by Monica Jaramillo

 

Reference:

Vitale M, et al. Paper #53. Presented at: Scoliosis Research Society Annual Meeting; September 6-9, 2017; Philadelphia.

Disclosure: Vitale reports no relevant financial disclosures.